Recent Advances in Natural Medicines for Treatment of Neurodegenerative diseases

Dear Colleagues,

Neurodegenerative diseases (NDDs) are a range of neurological disorders characterized by neuronal degeneration and apoptosis, including but not limited to Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS), etc. NDDs primarily manifest progressive impairment in cognitive, motor, and sensory functions, and severely affect the life quality of aged people nowadays. Currently, it’s generally considered that herbal medicines and their products are beneficial for controlling or preventing NDDs. Here we established a special issue "Recent Advances in Natural Medicines for Treatment of Neurodegenerative diseases" to invite investigators to submit both original research and review articles that explore the potential topics include but are not limited to the following:

●Novel natural products with activities against NDDs

●New strategies for finding potential drugs against NDDs from plants, animals, microorganisms and minerals, in particular Network pharmacology, Artificial intelligence, Computer aided design, etc.

●Novel drug-targets for natural agents against NDDs

●Recent advances of anti-NDDs agents from plants, animals, microorganisms and minerals and the potential molecular mechanisms

●Potential molecules from natural agents with the activities of alleviating toxicities of current available drugs against NDDs.

Dr. Wei Peng and Dr. Chuantao Zhang

Guest Editors

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.